SEC Form 4 · accession 0001192482-16-000638
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Gordon Freund
Director · 10% Owner
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $16.49 | Jun 9, 2016 | A | 8,700 | A | — | Jun 9, 2026 | Common Stock | 8,700 | 8,700 | D |
Explanation of responses
- F1The option vests and becomes exercisable on June 9, 2017, subject to the director's continued service with the issuer.